Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02683785 · ClinicalTrials.gov registry record · Phase 2
A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT02683785 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 44 participants.
The verdict
NCT02683785, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
This is a randomized, Phase IIa, multicentre, double-blind, placebo-controlled parallel group study with the primary objective to assess the efficacy potential of GSK3196165 on pain, in subjects with active inflammatory hand osteoarthritis (HOA). Approximately 40 subjects will be enrolled into the study, following a screening period of up to 4 weeks. The total treatment period will be 12 weeks, with the follow up period completing at Week 22. At least 40 subjects will be randomized across the two treatment arms, to either placebo or GSK3196165 in a 1:1 ratio.
Interventions
- DRUG Placebo
- DRUG GSK3196165
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-03-17 |
| Est. Completion | 2017-11-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02683785
The ClinicalTrials.gov registry entry for NCT02683785 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02683785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02683785 about?
NCT02683785 is a clinical study titled "A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis". This is a randomized, Phase IIa, multicentre, double-blind, placebo-controlled parallel group study with the primary objective to assess the efficacy potential of GSK3196165 on pain, in subjects with active inflammatory hand osteoarthritis (HOA). Approximately 40 subjects will be enrolled into the ...
What is the current status of trial NCT02683785?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2016-03-17. Estimated completion is 2017-11-29.
What interventions are being tested in trial NCT02683785?
The interventions under investigation include: Placebo (DRUG), GSK3196165 (DRUG).
Who is sponsoring clinical trial NCT02683785?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.